Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for profitable short-term investing, highlighting the need for sound fundamentals and positive earnings estimates to maintain momentum. Group 1: Trend Analysis - The trend in short-term investing is crucial, and confirming its sustainability is essential for profitability [1][2] - A predefined screen called "Recent Price Strength" helps identify stocks on an uptrend with strong fundamentals, indicating bullishness [3] Group 2: Company Spotlight - Betterware de Mexico SAPI de C (BWMX) - BWMX has shown a solid price increase of 26.7% over the past 12 weeks, reflecting investor confidence in its potential upside [4] - The stock has maintained a price increase of 0.4% over the last four weeks, indicating that the upward trend is still intact [5] - BWMX is trading at 87.3% of its 52-week high-low range, suggesting it may be on the verge of a breakout [5] Group 3: Fundamental Strength - BWMX holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6] - The Zacks Rank system has a strong track record, with Rank 1 stocks averaging an annual return of +25% since 1988 [7] - The Average Broker Recommendation for BWMX is also 1 (Strong Buy), indicating high optimism from the brokerage community regarding its near-term price performance [7] Group 4: Additional Opportunities - Besides BWMX, there are other stocks that meet the criteria of the "Recent Price Strength" screen, suggesting further investment opportunities [8] - The article encourages exploring over 45 Zacks Premium Screens tailored to different investing styles for potential winning stock picks [8]

Core Viewpoint - CBRE Group, Inc. is a prominent player in the commercial real estate services and investment industry, with a stable price target reflecting positive sentiment and growth expectations despite market fluctuations [1][2][6]. Group 1: Company Overview - CBRE operates through three main segments: Advisory Services, Global Workplace Solutions, and Real Estate Investments [1]. - Founded in 1906 and headquartered in Dallas, Texas, CBRE has established itself as a key player in the real estate market [1]. Group 2: Price Target and Analyst Sentiment - The consensus price target for CBRE has remained stable at $192 over the past month and quarter, indicating confidence in the company's performance [2][6]. - The price target has increased from $179.25 compared to last year, reflecting positive sentiment and growth expectations [2]. Group 3: Upcoming Earnings and Analyst Outlook - CBRE is set to announce its fourth-quarter 2025 earnings on February 12, with a history of surpassing earnings expectations driven by strong revenue growth and demand for outsourcing services [3][6]. - Analysts from Raymond James have set a lower price target of $111, suggesting a more cautious outlook for the upcoming earnings report [3]. - Despite the company's resilience, analysts note that it may not have the optimal combination of factors for an earnings beat in the upcoming report [5]. Group 4: Recognition and Strategic Developments - CBRE's inclusion in the Zacks Premium portfolio service's Focus List highlights its earnings growth and price strength, indicating its potential as a strong, market-beating stock [4][6]. - Investors are encouraged to monitor CBRE's earnings release and strategic developments for insights into future performance [4].

Core Viewpoint - The article emphasizes the importance of timing and sustainability in short-term investing, highlighting that while trends can be beneficial, ensuring their longevity is crucial for success [1][2]. Group 1: Stock Performance - Sumitomo Corp. (SSUMY) has shown a solid price increase of 13.6% over the past 12 weeks, indicating strong investor interest [4]. - SSUMY has maintained a price increase of 0.5% over the last four weeks, suggesting that the upward trend is still intact [5]. - The stock is currently trading at 90% of its 52-week high-low range, indicating a potential breakout [5]. Group 2: Fundamental Strength - SSUMY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term performance [7]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks like SSUMY that are on an uptrend supported by strong fundamentals [3]. - The article suggests that there are multiple stocks passing through the "Recent Price Strength" screen, indicating a broader opportunity for trend investing [8].

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for profitable short-term investing, highlighting the need for sound fundamentals and positive earnings estimates to maintain momentum. Group 1: Stock Performance - Verona Pharma PLC (VRNA) has shown a solid price increase of 74.2% over the past 12 weeks, indicating strong investor interest and potential upside [4] - The stock has also increased by 12.5% over the last four weeks, suggesting that the upward trend is still intact [5] - VRNA is currently trading at 94.8% of its 52-week high-low range, indicating a potential breakout [5] Group 2: Fundamental Strength - VRNA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6] - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7] Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks like VRNA that are on an uptrend supported by strong fundamentals [3] - The article suggests that there are several other stocks passing through this screen, indicating potential investment opportunities [8]